- 3201. out of jurisdiction
- [The medical service and/or product was provided to a patient that has coverage in another jurisdiction. ( HL7V3.0 )] (UMLS (HL7) C1555589) =Intellectual Product =ActInvoiceOverrideCode;
| - 3251. ovarian disease
- [disorders of ovarian function; varied pathology depending on the phase of the reproductive life from fetal stage to adulthood. ( CSP )] (UMLS (CSP) C0029928) =Disease or Syndrome =Adnexal Diseases;
gonad disorder;
Female Reproductive System Disease;
=Cyst of Ovary;
Neoplasm of Ovary;
Anovulation;
Oophoritis;
Cyst of Ovary;
Ovarian Hyperstimulation Syndrome;
Ovarian Failure;
Neoplasm of Ovary |
- 3202. out of office
- [Premium paid on service fees in compensation for practicing at a location other than normal working location. ( HL7V3.0 )] (UMLS (HL7) C1555679) =Intellectual Product =ActInvoiceDetailGenericModifierCode;
| - 3252. Ovarian dysfunction
- [ ] (UMLS (ICD9CM) C0154208) =Disease or Syndrome
|
- 3203. out of stock
- [In the case of 'substitution', indicates that the substitution occurred because the ordered item was not in stock. In the case of 'no substitution', indicates that a cheaper equivalent was not substituted because it was not in stock. ( HL7V3.0 )] (UMLS (HL7) C1553902) =Idea or Concept =SubstanceAdminSubstitutionReason;
| - 3253. Ovarian Embryonal Carcinoma Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes peritoneal metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336431) Stage IV Ovarian Embryonal Carcinoma =Neoplastic Process
|
- 3204. Out-of-Pocket Expense
- [Uninsured Medical Expense; payment for the uninsured portion of regular medical expenses, such as co-payments, deductibles, and uncovered expenses. Uninsured medical expense encompasses a range of items that includes co-payments, medicine costs, uncovered procedures and conditions, as well as cash payments in lieu of health insurance. ( NCI )] (UMLS (NCI) C0237129) =Finding ;
| - 3254. Ovarian Embryonal Carcinoma, Stage I
- [Stage I includes: (T1, N0, M0). Also, IA: (T1a, N0, M0); IB: (T1b, N0, M0); IC (T1c, N0, M0). T1: Tumor limited to ovaries (one or both). T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1b: Tumor limited to one or both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336472) Stage I Ovarian Embryonal Carcinoma =Neoplastic Process
|
- 3205. Outcome
- [A phenomenon that follows and is caused by some previous phenomenon. ( NCI )] (UMLS (NCI) C1274040) Result;
Results =Functional Concept | - 3255. Ovarian Embryonal Carcinoma, Stage II
- [Stage II includes: (T2, N0, M0). Also, IIA: (T2a, N0, M0); IIB: (T2b, N0, M0); IIC: (T2c, N0, M0). T2: Tumor involves one or both ovaries with pelvic extension and/or implants. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. T2b: Extension to and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings. N0: No regional metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336308) Stage II Ovarian Embryonal Carcinoma =Neoplastic Process
|
- 3206. outcome assessment
- [Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). ( MSH )] (UMLS (CSP) C0085565) =Occupational Activity ;
| - 3256. Ovarian Embryonal Carcinoma, Stage III
- [Stage III includes: (T3, N0, M0). Also, IIIA: (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c N0, M0) and (Any T, N1, M0). T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336261) Stage III Ovarian Embryonal Carcinoma =Neoplastic Process
|
- 3207. Outcome of delivery
- [ ] (UMLS (ICD9CM) C0260581) =Finding
| - 3257. Ovarian Endometrioid Adenofibroma
- [A benign neoplasm of the ovary characterized by the presence of glandular or cystic structures lined by endometrial-type well-differentiated cells in a fibrotic stroma. ( NCI )] (UMLS (NCI) C1335157) =Neoplastic Process
|
- 3208. outcome prediction
- [prediction as to the probable outcome of a disease or disorder as indicated by the nature and symptoms of the case. ( CSP )] (UMLS (CSP) C0033325) =Health Care Activity =Pathologic Process;
| - 3258. Ovarian Endometrioid Cystadenofibroma
- (UMLS (NCI) C1335158) =Neoplastic Process
|
- 3209. outcomes research
- [research aimed at assessing the quality and effectiveness of particular health care practices and interventions as measured by the attainment of a specified end result; for complete retrieval include RTs. ( CSP )] (UMLS (CSP) C0086750) =Research Activity ;
=evaluation/testing;
tag term | - 3259. Ovarian Failure
- [A loss of ovarian function in women under 40. ( NCI )] (UMLS (NCI) C0085215) =Disease or Syndrome =ovarian disease;
|
- 3210. Outer Nuclear Layer
- (UMLS (NCI) C0229210) =Body Part, Organ, or Organ Component
| - 3260. ovarian follicle
- [An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. ( MSH )] (UMLS (CSP) C0018120) =Body Part, Organ, or Organ Component
|
- 3211. Outer Plexiform Layer
- (UMLS (NCI) C0229217) =Body Part, Organ, or Organ Component
| - 3261. Ovarian Germ Cell Choriocarcinoma Stage II
- [Stage II includes: (T2, N0, M0). Also, IIA: (T2a, N0, M0); IIB: (T2b, N0, M0); IIC: (T2c, N0, M0). T2: Tumor involves one or both ovaries with pelvic extension and/or implants. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. T2b: Extension to and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings. N0: No regional metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854942) Ovarian Germ Cell Choriocarcinoma, Stage II;
Stage II Ovarian Choriocarcinoma;
Stage II Ovarian Germ Cell Choriocarcinoma =Neoplastic Process |
- 3212. outer space
- [ ] (UMLS (CSP) C0599510) =Spatial Concept ;
| - 3262. Ovarian Germ Cell Choriocarcinoma Stage III
- [Stage III includes: (T3, N0, M0). Also, IIIA: (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c N0, M0) and (Any T, N1, M0). T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854943) Ovarian Germ Cell Choriocarcinoma, Stage III;
Stage III Ovarian Choriocarcinoma;
Stage III Ovarian Germ Cell Choriocarcinoma =Neoplastic Process |
- 3213. OUTLET CONTRACT-ANTEPART
- [ ] (UMLS (ICD9CM) C0156980) =Acquired Abnormality; Disease or Syndrome
| - 3263. Ovarian Germ Cell Choriocarcinoma Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes peritoneal metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854944) Ovarian Germ Cell Choriocarcinoma, Stage IV;
Stage IV Ovarian Choriocarcinoma;
Stage IV Ovarian Germ Cell Choriocarcinoma =Neoplastic Process |
- 3214. Outlet contraction of pelvis in pregnancy, labor, and delivery
- [ ] (UMLS (ICD9CM) C0156977) =Acquired Abnormality; Disease or Syndrome
| - 3264. Ovarian Germ Cell Monodermal and Highly Specialized Teratoma
- (UMLS (NCI) C0280134) =Neoplastic Process
|
- 3215. Outlet contraction of pelvis, delivered
- [ ] (UMLS (ICD9CM) C0156979) =Anatomical Abnormality ;
| - 3265. Ovarian Germ Cell Teratoma Stage II
- [Stage II includes: (T2, N0, M0). Also, IIA: (T2a, N0, M0); IIB: (T2b, N0, M0); IIC: (T2c, N0, M0). T2: Tumor involves one or both ovaries with pelvic extension and/or implants. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. T2b: Extension to and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings. N0: No regional metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854956) Ovarian Germ Cell Teratoma, Stage II;
Stage II Ovarian Germ Cell Teratoma;
Stage II Ovarian Teratoma =Neoplastic Process |
- 3216. Outlet contraction of pelvis, unspecified as to episode of care in pregnancy
- [ ] (UMLS (ICD9CM) C0156978) =Acquired Abnormality; Disease or Syndrome
| - 3266. Ovarian Germ Cell Teratoma Stage III
- [Stage III includes: (T3, N0, M0). Also, IIIA: (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c N0, M0) and (Any T, N1, M0). T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854957) Ovarian Germ Cell Teratoma, Stage III;
Stage III Ovarian Germ Cell Teratoma;
Stage III Ovarian Teratoma =Neoplastic Process |
- 3217. OUTLET DYSFNC CONSTPTION
- [ ] (UMLS (ICD9CM) C0949134) Outlet dysfunction constipation =Disease or Syndrome
| - 3267. Ovarian Germ Cell Teratoma Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes peritoneal metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854958) Ovarian Germ Cell Teratoma, Stage IV;
Stage IV Ovarian Germ Cell Teratoma;
Stage IV Ovarian Teratoma =Neoplastic Process |
- 3218. Outlier cost
- (UMLS (HL7) C1548153) =Idea or Concept =Outlier Type;
| - 3268. Ovarian Granulosa Cell
- [A cuboidal cell derived from a spindle-shaped granulosa cell precursor. Initially, ovarian granulosa cells create a single layer surrounding an oocyte. The oocyte and its single layer of ovarian granulosa cells make up a primary follicle. Proliferation of the ovarian granulosa cells leads to multiple cell layers surrounding the oocyte and maturation into a secondary follicle. The granulosa cells extend cytoplasmic processes to form gestational gap-junction-like unions with the plasma membrane of the oocyte. The continued growth of the ovarian granulosa cells takes the oocyte to the Graafian follicle stage. Once ovulation occurs, the granulosa cells become part of the corpus luteum. A major function of an ovarian granulosa cell is hormone production and secretion. ( NCI )] (UMLS (NCI) C1178844) =Cell
|
- 3219. Outlier days
- (UMLS (HL7) C1548154) =Idea or Concept =Outlier Type;
| - 3269. Ovarian Granulosa-Stromal Cell Tumor
- (UMLS (NCI) C1335162) =Neoplastic Process
|
- 3220. Outlier Type
- (UMLS (HL7) C1550368) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Outlier cost;
Outlier days;
| - 3270. Ovarian Insufficiency
- (UMLS (NCI) C1401084) =Disease or Syndrome
|
- 3221. Outpatient
- (UMLS (HL7) C1548439) =Idea or Concept =Referral category;
| - 3271. Ovarian Medulla
- [The central portion of the ovary, composed of loose connective tissue that contains blood vessels, lymph vessels and nerves. ( NCI )] (UMLS (NCI) C0227879) =Body Part, Organ, or Organ Component
|
- 3222. Outpatient
- (UMLS (HL7) C1549405) =Classification =Patient Class;
| - 3272. Ovarian Mixed Germ Cell-Sex Cord Neoplasm
- (UMLS (NCI) C1335166) Ovarian Mixed Germ Cell-Sex Cord Tumor;
Ovarian Mixed Germ Cell-Sex Cord-Stromal Neoplasm;
Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor =Neoplastic Process |
- 3223. outpatient
- [A patient who visits a health care facility for diagnosis or treatment without spending the night. Sometimes called a day patient. ( NCI )] (UMLS (NCI) C0029921) =Patient or Disabled Group
| - 3273. Ovarian Non-Neoplastic Disease
- (UMLS (NCI) C1335173) Ovarian Non-Neoplastic Disorder =Disease or Syndrome
|
- 3224. Outpatient elective
- (UMLS (HL7) C1549492) =Idea or Concept =Certification patient type;
| - 3274. Ovarian Pap Test
- (UMLS (NCI) C0879459) Ovarian Papanicolaou Test =Laboratory Procedure ;
|
- 3225. Outpatient facility
- (UMLS (HL7) C1550683) =Intellectual Product =DedicatedClinicalLocationRoleType;
=Infectious disease clinic;
Cardiology clinic;
General internal medicine clinic;
Rheumatology clinic;
Sports medicine clinic;
Allergy clinic;
Amputee clinic;
Bone marrow transplant clinic;
Breast clinic;
Child and adolescent neurology clinic;
Child and adolescent psychiatry clinic;
Coagulation clinic;
Colon and rectal surgery clinic;
Dermatology clinic;
Endocrinology clinic;
Otorhinolaryngology clinic;
Family medicine clinic;
Gastroenterology clinic;
Gynecology clinic;
Hematology clinic;
Hypertension clinic;
Impairment evaluation center;
Infertility clinic;
Lympedema clinic;
Medical genetics clinic;
Nephrology clinic;
Neurology clinic;
Obstetrics clinic;
Medical oncology clinic;
Opthalmology clinic;
Orthopedics clinic;
"Ambulatory Health Care Facilities; Clinic/Center; Primary Care"
;Pediatrics clinic;
Preventive medicine clinic;
Proctology clinic;
Prosthodontics clinic;
Psychology clinic;
Psychiatry clinic;
Surgery clinic;
Transplant clinic;
Travel and geographic medicine clinic;
Wound clinic;
Provider's Office;
"Ambulatory Health Care Facilities; Clinic/Center; Surgery, Oral/Maxillofacial"
;"Ambulatory Health Care Facilities; Clinic/Center; Rehabilitation: Cardiac Facilities"
;"Ambulatory Health Care Facilities; Clinic/Center; Podiatric"
;"Ambulatory Health Care Facilities; Clinic/Center; Pain" | - 3275. Ovarian Papillary Cystadenoma
- (UMLS (NCI) C1335175) =Neoplastic Process
|
- 3226. Outpatient Order
- (UMLS (HL7) C1547560) =Idea or Concept =Order Type;
| - 3276. Ovarian Papillary Neoplasm
- (UMLS (NCI) C0476121) =Neoplastic Process
|
- 3227. Outpatient Prospective Payment System
- (UMLS (HL7) C1547526) =Intellectual Product =Reimbursement Type Code;
| - 3277. Ovarian Polyembryoma Stage I
- [Stage I includes: (T1, N0, M0). Also, IA: (T1a, N0, M0); IB: (T1b, N0, M0); IC (T1c, N0, M0). T1: Tumor limited to ovaries (one or both). T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1b: Tumor limited to one or both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336473) Stage I Ovarian Polyembryoma =Neoplastic Process
|
- 3228. outreach
- [ ] (UMLS (CSP) C0683805) =Self-help or Relief Organization ;
| - 3278. Ovarian Polyembryoma Stage II
- [Stage II includes: (T2, N0, M0). Also, IIA: (T2a, N0, M0); IIB: (T2b, N0, M0); IIC: (T2c, N0, M0). T2: Tumor involves one or both ovaries with pelvic extension and/or implants. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. T2b: Extension to and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings. N0: No regional metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336309) Stage II Ovarian Polyembryoma =Neoplastic Process
|
- 3229. outreach program
- [ ] (UMLS (CSP) C0871024) =Self-help or Relief Organization ;
| - 3279. Ovarian Polyembryoma Stage III
- [Stage III includes: (T3, N0, M0). Also, IIIA: (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c N0, M0) and (Any T, N1, M0). T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336262) Stage III Ovarian Polyembryoma =Neoplastic Process
|
- 3230. Outside Lab
- (UMLS (HL7) C1547992) =Intellectual Product =Diagnostic Service Section ID;
| - 3280. Ovarian Polyembryoma Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes peritoneal metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336432) Stage IV Ovarian Polyembryoma =Neoplastic Process
|
- 3231. outside threshold
- [ Definition:The observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported. Example:A positive result on a Hepatitis screening test. ( HL7V3.0 )] (UMLS (HL7) C1698059) =Qualitative Concept ;
=ObservationInterpretation;
| - 3281. OVARIAN PREG W INTRA PRG
- [ ] (UMLS (ICD9CM) C1135236) Ovarian pregnancy with intrauterine pregnancy;
=Disease or Syndrome |
- 3232. OVA BiP Peptide
- [A 19 amino acids hybrid peptide antigen with immune adjuvant property. OVA-BiP peptide consists of 8 amino acids from ovalbumin joined via a tripeptide linker to a stretch of 8 amino acids, the minimum binding domain of BiP (immunoglobulin heavy chain-binding protein, aka grp78), a member of the heat shock protein (hsp) 70 family. As a chaperon, BiP binds to newly synthesized, unfolded mu immnoglobulin heavy chain prior to its assembly with light chain in the endoplasmic reticulum. In conjunction with a tumor antigen, this hybrid peptide is used to potentiate antigen presentation and consequently prime cytotoxic T lymphocyte responses. ( NCI )] (UMLS (NCI) C0879487) OVA-BiP Hybrid Peptide;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 3282. Ovarian pregnancy
- (UMLS (ICD9CM) C0032991) =Disease or Syndrome ;
|
- 3233. oval cell
- [ ] (UMLS (CSP) C0872357) =Cell ;
| - 3283. Ovarian pregnancy without intrauterine pregnancy
- [ ] (UMLS (ICD9CM) C1135235) OVARN PREG W/O INTRA PRG;
=Disease or Syndrome |
- 3234. OVAL WINDOW FISTULA
- [ ] (UMLS (ICD9CM) C0339782) =Acquired Abnormality
| - 3284. Ovarian Rhabdomyosarcoma
- [A malignant mesenchymal tumor with skeletal muscle differentiation affecting the ovaries. ( NCI )] (UMLS (NCI) C1335176) Rhabdomyosarcoma of Ovary;
Rhabdomyosarcoma of the Ovary;
=Neoplastic Process |
- 3235. ovalbumin
- [albumin obtained from the white of eggs. ( CSP )] (UMLS (CSP) C0029923) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=egg protein;
Phosphoprotein | - 3285. Ovarian Sarcoma
- (UMLS (NCI) C0280746) =Neoplastic Process
|
- 3236. OVALE MALARIA
- (UMLS (ICD9CM) C0152072) =Disease or Syndrome
| - 3286. Ovarian Sclerosing Stromal Neoplasm
- [A benign ovarian stromal tumor characterized by the presence of cellular areas which contain fibroblasts and round cells. The cellular areas are separated by sclerotic or edematous hypocellular tissue. Symptoms include abdominal discomfort and menstrual abnormalities. ( NCI )] (UMLS (NCI) C1368821) Ovarian Sclerosing Stromal Tumor;
Sclerosing Stromal Neoplasm of Ovary;
Sclerosing Stromal Neoplasm of the Ovary;
Sclerosing Stromal Tumor of Ovary;
Sclerosing Stromal Tumor of the Ovary =Neoplastic Process |
- 3237. OvaRex
- (UMLS (NCI) C0664206) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 3287. Ovarian Serous Adenocarcinoma
- [Ovarian serous adenocarcinoma is a serous neoplasm characterized by nuclear atypia, high mitotic activity, stratification, glandular complexity, branching papillary fronds and stromal invasion. —2002 ( NCI )] (UMLS (NCI) C1335177) Ovarian Serous Carcinoma;
Serous Adenocarcinoma of Ovary;
Serous Adenocarcinoma of the Ovary;
Serous Carcinoma of Ovary;
Serous Carcinoma of the Ovary =Neoplastic Process |
- 3238. ovarian
- [Having to do with the ovaries, the female reproductive glands in which the ova (eggs) are formed. The ovaries are located in the pelvis, one on each side of the uterus. ( NCI )] (UMLS (NCI) C0205065) =Body Part, Organ, or Organ Component ;
| - 3288. Ovarian Serous Cystadenocarcinoma
- (UMLS (NCI) C0279663) =Neoplastic Process
|
- 3239. ovarian ablation
- [Surgery, radiation therapy, or a drug treatment to stop the functioning of the ovaries. ( NCI )] (UMLS (NCI) C0677922) =Therapeutic or Preventive Procedure ;
| - 3289. Ovarian Serous Cystadenofibroma
- (UMLS (NCI) C0877572) =Neoplastic Process
|
- 3240. Ovarian Adenosarcoma
- (UMLS (NCI) C1335169) Ovarian Mesodermal Adenosarcoma;
Ovarian Mullerian Adenosarcoma;
=Neoplastic Process | - 3290. Ovarian Serous Neoplasm
- [Serous tumors make up about one fourth of all ovarian tumors. About 30% to 50% are bilateral. Grossly, the better differentiated tumors consist of cystic masses, usually unilocular, containing a clear but sometimes viscous fluid. Papillary formations are often present. The more malignant tumors tend to be solid and invasive, with areas of necrosis and hemorrhage. It is now accepted that a morphologic spectrum exists in these tumors. At one end is the benign serous cystadenoma and at the other end are serous adenocarcinoma, serous papillary adenocarcinoma and serous papillary cystadenocarcinoma. In between are tumors showing some or all of the features associated with carcinoma but lacking definite stromal invasion. These tumors make up about 15% of all serous tumors and are known as borderline, indeterminate, intermediate, of low malignant potential or possibly malignant. In some serous tumors the fibroblastic stromal component is unduly prominent. Theses tumors can be separated into benign (adenofibroma and cystadenofibroma), borderline and malignant (malignant adenofibroma and malignant cystadenofibroma). —2002 ( NCI )] (UMLS (NCI) C0476122) =Neoplastic Process
|
- 3241. Ovarian Artery
- (UMLS (NCI) C0226411) =Body Part, Organ, or Organ Component
| - 3291. Ovarian Serous Surface Papillary Adenocarcinoma
- (UMLS (NCI) C1335178) Serous Surface Papillary Carcinoma of Ovary;
Serous Surface Papillary Carcinoma of the Ovary;
=Neoplastic Process |
- 3242. Ovarian Cancer Prevention
- (UMLS (NCI) C0281659) =Therapeutic or Preventive Procedure ;
| - 3292. Ovarian Sex Cord-Stromal Neoplasm
- (UMLS (NCI) C0600113) =Neoplastic Process ;
|
- 3243. Ovarian Capsule
- (UMLS (NCI) C0227877) =Body Part, Organ, or Organ Component
| - 3293. Ovarian Small Cell Carcinoma
- (UMLS (NCI) C1335179) =Neoplastic Process
|
- 3244. Ovarian Cellular Fibroma
- [A benign neoplasm arising from soft tissue of the ovary. It is characterized by the presence of spindle-shaped fibroblasts and increased cellularity. ( NCI )] (UMLS (NCI) C1335154) =Neoplastic Process ;
| - 3294. Ovarian Soft Tissue Neoplasm
- (UMLS (NCI) C1335180) Ovarian Soft Tissue Tumor;
Soft Tissue Neoplasm of Ovary;
Soft Tissue Neoplasm of the Ovary;
Soft Tissue Tumor of Ovary;
Soft Tissue Tumor of the Ovary =Neoplastic Process |
- 3245. Ovarian Clear Cell Cystadenocarcinoma
- [A malignant glandular epithelial tumor arising from the ovary. It is characterized by the presence of clear and hobnail cells and cystic structures. ( NCI )] (UMLS (NCI) C0279667) =Neoplastic Process
| - 3295. Ovarian Solid Teratoma
- (UMLS (NCI) C1335181) =Neoplastic Process
|
- 3246. Ovarian Clear Cell Neoplasm
- [A benign, borderline or malignant glandular epithelial neoplasm characterized by a predominance of clear and hobnail cells. ( NCI )] (UMLS (NCI) C0346164) =Neoplastic Process
| - 3296. Ovarian Surface Papilloma
- (UMLS (NCI) C1335183) =Neoplastic Process
|
- 3247. Ovarian Cortex
- [The outer layer of the ovary, composed of cellular connective tissue which contains the ovarian follicles. ( NCI )] (UMLS (NCI) C0227878) =Body Part, Organ, or Organ Component
| - 3297. OVARIAN TORSION RELEASE
- (UMLS (ICD9CM) C0195553) =Therapeutic or Preventive Procedure
|
- 3248. Ovarian Cystic Teratoma
- (UMLS (NCI) C1335155) =Neoplastic Process
| - 3298. Ovarian Transitional Cell Carcinoma
- (UMLS (NCI) C1335184) Transitional Cell Carcinoma of Ovary;
Transitional Cell Carcinoma of the Ovary =Neoplastic Process |
- 3249. OVARIAN DENERVATION
- (UMLS (ICD9CM) C0195583) =Therapeutic or Preventive Procedure
| - 3299. Ovarian Transitional Cell Neoplasm
- (UMLS (NCI) C1335185) Ovarian Transitional Cell Tumor;
=Neoplastic Process |
- 3250. Ovarian Dermoid Cyst with Secondary Tumor
- (UMLS (NCI) C1335156) =Neoplastic Process
| - 3300. Ovarian Tumor of the Thecoma/Fibroma Group
- (UMLS (NCI) C1336734) Thecoma/Fibroma Group Ovarian Tumor =Neoplastic Process ;
|
home
